Im, Jae Hong
Buzzelli, Jon N.
Jones, Keaton
Franchini, Fanny http://orcid.org/0000-0002-4522-3385
Gordon-Weeks, Alex http://orcid.org/0000-0003-2997-4194
Markelc, Bostjan
Chen, Jianzhou http://orcid.org/0000-0002-3645-3904
Kim, Jin
Cao, Yunhong
Muschel, Ruth J. http://orcid.org/0000-0002-5656-5970
Funding for this research was provided by:
Cancer Research UK (C5255/A15935, C5255/A15935, C5255/A15935, C5255/A15935, C5255/A15935, C5255/A15935, C5255/A15935)
Article History
Received: 12 January 2018
Accepted: 6 July 2020
First Online: 13 August 2020
Competing interests
: The authors declare the following competing interests: Jin Kim is the Chief Scientific Officer of Galaxy Biotec, which supplied the FGF2 blocking antibody, GAL-F2 used in this study.